title: Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice.
abstract: Prostaglandin E(2) (PGE(2)) acts as a potent stimulator of bone resorption. In this study, we first clarified in normal ddy mice the involvement of protein kinase A and induction of matrix metalloproteinases (MMPs) in PGE(2)-induced bone resorption, and then identified PGE receptor subtype(s) mediating this PGE(2) action using mice lacking each subtype (EP1, EP2, EP3, and EP4) of PGE receptor. In calvarial culture obtained from normal ddy mice, both PGE(2) and dibutyryl cyclic AMP (Bt(2)cAMP) stimulated bone resorption and induced MMPs including MMP-2 and MMP-13. Addition of an inhibitor of protein kinase A, H89, or an inhibitor of MMPs, BB94, significantly suppressed bone-resorbing activity induced by PGE(2.) In calvarial culture from EP1-, EP2-, and EP3-knockout mice, PGE(2) stimulated bone resorption to an extent similar to that found in calvaria from the wild-type mice. On the other hand, a marked reduction in bone resorption to PGE(2) was found in the calvarial culture from EP4-knockout mice. The impaired bone resorption to PGE(2) was also detected in long bone cultures from EP4-knockout mice. Bt(2)cAMP greatly stimulated bone resorption similarly in both wild-type and EP4-knockout mice. Induction of MMP-2 and MMP-13 by PGE(2) was greatly impaired in calvarial culture from EP4-knockout mice, but Bt(2)cAMP stimulated MMPs induction similarly in the wild-type and EP4-knockout mice. These findings suggest that PGE(2) stimulates bone resorption by a cAMP-dependent mechanism via the EP4 receptor.
authors.affiliation: Department of Biochemistry, School of Dentistry, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.
authors.forename: C
authors.initials: C
authors.lastname: Miyaura
authors.forename: M
authors.initials: M
authors.lastname: Inada
authors.forename: T
authors.initials: T
authors.lastname: Suzawa
authors.forename: Y
authors.initials: Y
authors.lastname: Sugimoto
authors.forename: F
authors.initials: F
authors.lastname: Ushikubi
authors.forename: A
authors.initials: A
authors.lastname: Ichikawa
authors.forename: S
authors.initials: S
authors.lastname: Narumiya
authors.forename: T
authors.initials: T
authors.lastname: Suda
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D015152:Blotting, Northern; D015153:Blotting, Western; D001862:Bone Resorption / Q000235:genetics*; D003994:Bucladesine / Q000378:metabolism; D002478:Cells, Cultured; D017364:Collagenases / Q000378:metabolism; D015232:Dinoprostone / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D018093:Gelatinases / Q000378:metabolism; D005838:Genotype; D051379:Mice; D018345:Mice, Knockout; D016133:Polymerase Chain Reaction; D018078:Receptors, Prostaglandin E / Q000235:genetics* / Q000378:metabolism* / Q000502:physiology; D058306:Receptors, Prostaglandin E, EP1 Subtype; D058309:Receptors, Prostaglandin E, EP4 Subtype; D015398:Signal Transduction / Q000235:genetics; D012886:Skull / Q000378:metabolism
chemical_list: C545636:Ptger1 protein, mouse; C545651:Ptger4 protein, mouse; D018078:Receptors, Prostaglandin E; D058306:Receptors, Prostaglandin E, EP1 Subtype; D058309:Receptors, Prostaglandin E, EP4 Subtype; D003994:Bucladesine; D017364:Collagenases; D018093:Gelatinases; D015232:Dinoprostone